Meet the CEO’s: Connect with leading Australian Small Cap CEOs

Connect with leading ASX listed Companies

Meeting the CEO’s – Online Investor Briefing

Wednesday 27th May 12pm-1pm AEST

Get a seat at the table and hear directly from CEOs and business leaders.
This week join 3 CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects.

Event Details:
Date: Wednesday 27 May 2020
Event agenda: Online, 3 x 15 minute presentations
Time: 12pm – 1pm AEST

This week we will be joined by:

  • Steven Yatomi-Clarke, from Prescient Therapeutics (ASX: PTX)
  • Scott Williamson, from Blackstone Minerals Limited (ASX:BSX)
  • Brent Barnes, from LBT Innovations Limited (ASX:LBT)

This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.

Attend this session

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

Featured Speakers

Scott Williamson

Managing Director - Blackstone Minerals Limited

Blackstone Minerals (ASX:BSX) is a leading battery and precious metals exploration and development company with an international portfolio of high-quality battery and precious metals exploration projects across South East Asia, North America and Australia.

STEVEN YATOMI-CLARKE

CEO and Managing Director - Prescient Therapeutics

Prescient Therapeutics (ASX:PTX) is focused on developing novel, personalised therapies against a range of cancers. Prescient’s universal CAR-T and targeted therapies are both personalised medicine approaches that seek to improve patient outcomes and provide new tools for clinicians in combating cancer.

Brent Barnes

Chief Executive Officer and Managing Director - LBT Innovations

LBT Innovations (ASX:LBT) is a groundbreaking designer of advanced technology solutions for the medical industry. We specialise in bringing advanced medical technologies to market. Our core capabilities include artificial intelligence, image analysis and software engineering solutions that improve medical diagnostic workflows.